Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Find out more

Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Find out more

Integrated
Drug Discovery

Target
Validation

Hit
Identification

Hit
to Lead

Lead
Optimization

IRBM Brochure
Corporate Brochure

We have been instrumental in the discovery of four drugs now on the market

We leverage our accomplishments in drug discovery with our determination to remain at the cutting edge of research to deliver innovation for industry and academia. As your partner, we provide you with robust and cutting edge scientific expertise, honed in global pharma, along with the steadfast support required in a fast-paced and challenging industry.

IRBM Passion

PASSION

Science is our cornerstone. Our unprecedented track record in discovering drugs demonstrates this. We capitalize on our shared enthusiasm for innovative R&D, spurred on by our dedication to deliver excellence at every opportunity.

IRBM Expertise

EXPERTISE

Our expertise spans different modalities including small molecule, peptide and biologic therapeutics. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.

IRBM Collaboration

COLLABORATION

Our partners are of the utmost importance. We always strive to go above and beyond your expectations, treating your projects as our highest priority.

WHYUS

We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.

Publications

Read more

Track Record

Read more

LatestNews

A new publication covering a highly successful drug discovery collaboration between Merck & Co and IRBM

Discovery Of MK-1462: GLP-1 And Glucagon Receptor Dual Agonist For The Treatment Of Obesity And Diabetes

Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes

8 August 2022
News, Publications, Publications 2022
The IRBM peptide chemistry team is proud to announce a new publication in ACS Medicinal Chemistry Letters in collaboration with the outstanding drug discovery team at Merck & Co. (Kenilworth, NJ).
Read more →

Women in the Chemical industry on June 14th at University of Salerno

14 June 2022
Events
Dr. Elisabetta Bianchi, Director, Peptide Chemistry has been invited as a speaker to the Symposium "Creativity, Innovation, Team Spirit and Leadership: Women in the Chemical Industry" to be held on 14 June 2022 at the Department of Chemistry and Biology "A. Zambelli" - University of Salerno.

IRBM publish malaria breakthrough research in Nature Communications Biology

8 June 2022
News, Press Releases, Publications, Publications 2022
In a collaboration with Istituto Superiore di Sanità and CNR, IRBM has published research that identified new molecules which block the transmission of the malaria parasite from an infected person to the mosquito, the first step in developing new drugs to eliminate this major infectious disease.

BIO 2022, June 13-16, 2022

23 May 2022
Events
The Power of NMR in Drug Discovery

The Power of NMR in Drug Discovery

Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.

read more
Back To Top